Lyrus is a research and technology driven global specialty pharmaceutical company committed to develop differentiated and innovative products
Lyrus with a vision to establish itself as a trusted partner of choice for innovative drug delivery solutions is equipped with a world class Research & Development Infrastructure. Most noteworthy it has a strong team of qualified professionals with decades of success in the industry.
What We Do
BUSINESS AREAS
Lyrus’s R&D infrastructure and team is a one stop solution for formulation development needs.
Our cGMP facilities house a number of new technological solutions to support our clients in the development and commercialization of their drug product in the global marketplace.
Lyrus has a substantial portfolio of high quality and affordable medicines aimed at chronic and critical therapies.
LYRUS PROVIDES END TO END FORMULATION DEVELOPMENT SOLUTION
FORMULATION DEVELOPMENT
November 2016
Pre Formulation
We do a comprehensive pre formulation study to ensure a robust dosage form that can sustain the rigors of processing and shelf life. Our aim remains to minimize the failure rate, reduced cost of development [...]
Formulation Development
Our pool of formulation development scientists are experts in advanced technologies covering: NDDS Novel Platform Technologies Nano Technology/Bioavailability enhancement Nutraceuticals
Analytical Development
Our Analytical Development team provides dedicated services and support to customers for all phases of drug development. All work is performed to cGMP and ICH guidelines
Pilot and Exhibit Manufacturing
We offer the integration of development laboratory with industrial manufacturing facilities and assure that successful laboratory scale products will be able to coup with industrial production processes
Regulatory
A team of experienced and qualified professionals with up-to-date regulatory awareness ensures a strong support to formulation development team and also our real-time response to any change in the regulatory environment, assuring regular dossier updates.
ACUTE TO CHRONIC… TECHNOLOGY
DRIVES OUR GLOBAL PORTFOLIO
OUR THERAPEUTIC SEGMENTS
Neuropsychiatry is one of our major focus therapy areas where we are working on various molecules with challenging delivery systems and new dosage forms.
Wide range of products including fixed dose combinations
We have plans for gaining leadership position in selected molecules globally by achieving total integration while completing the entire range of products in Diabetic portfolio.
We have products addressing Hyper and Hypothyroidism
Complete range of products for Urology segment including complementary products
We are building a complete range of PPIs in all dosage forms as well as other niche molecules in the segment.
Lyrus has developed some robust platform technologies for conventional topical preparations which assist in better application and bio-availability. This includes Nano technology and base modification. Available topicals are being developed in form of Cream, Gels, Topical Sprays, Oral Sprays etc.
While developing a wide range of products we are also focusing on compliance and unaddressed segments with unique platform technologies like “Rapid Crystals”
One of the most experienced team in Amoxclav range of products is developing a wide range in all dosage forms
A wide range of OTC products including oral solids, liquids, dry powders for reconstitution and dry powders in sachets etc. make a robust portfolio. All our products are “Sugar Free” and contain natural flavors.